# Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib

> **NCT02131298** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Palbociclib Alone
- **DRUG:** Palbociclib plus itraconazole

## Key facts

- **NCT ID:** NCT02131298
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02131298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02131298, "Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02131298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*